Pth (parathyroid hormone) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Pth (parathyroid hormone) Rattus norvegicus
Symbol: Pth
Name: parathyroid hormone
RGD ID: 3440
Description: Enables hormone activity; peptide hormone receptor binding activity; and type 1 parathyroid hormone receptor binding activity. Involved in several processes, including Rho protein signal transduction; negative regulation of chondrocyte differentiation; and regulation of bone mineralization. Acts upstream of or within adenylate cyclase-activating G protein-coupled receptor signaling pathway and intracellular calcium ion homeostasis. Located in extracellular space. Used to study several diseases, including chronic kidney disease; hyperphosphatemia; nephrocalcinosis; osteoporosis; and secondary hyperparathyroidism. Biomarker of autosomal dominant hypocalcemia; kidney failure (multiple); osteoporosis; and secondary hyperparathyroidism. Human ortholog(s) of this gene implicated in several diseases, including chronic kidney disease; diabetes mellitus (multiple); familial isolated hypoparathyroidism; hyperphosphatemia; and secondary hyperparathyroidism. Orthologous to human PTH (parathyroid hormone); PARTICIPATES IN parathyroid hormone signaling pathway; INTERACTS WITH 1,25-Dihydroxy-16-ene-vitamin D3; 24,25-Dihydroxyvitamin D; 3',5'-cyclic AMP.
Type: protein-coding
Previously known as: hypothalamic parathyroid hormone; parathyrin; PTH-(1-84); Pth1; Pthr1
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Orthologs
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr81176,942,901 - 176,946,034 (-)NCBIGRCr8
mRatBN7.21167,508,121 - 167,511,530 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1167,508,598 - 167,511,530 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1175,843,980 - 175,846,912 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01183,030,070 - 183,033,002 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01175,725,437 - 175,728,369 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01178,215,829 - 178,218,761 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1178,215,829 - 178,218,761 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01185,183,456 - 185,186,388 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41171,240,596 - 171,243,528 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11171,360,529 - 171,363,462 (-)NCBI
Celera1165,378,267 - 165,381,199 (-)NCBICelera
Cytogenetic Map1q33NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
1,25-Dihydroxy-16-ene-vitamin D3  (EXP)
17beta-estradiol  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
24,25-Dihydroxyvitamin D  (EXP,ISO)
3',5'-cyclic AMP  (EXP)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (EXP)
3,3',4,4',5-pentachlorobiphenyl  (EXP)
3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione  (ISO)
8-Br-cAMP  (ISO)
adenine  (EXP)
alfacalcidol  (EXP)
aluminium atom  (ISO)
aluminium(0)  (ISO)
ammonium chloride  (EXP)
arsane  (ISO)
arsenic atom  (ISO)
benzo[a]pyrene  (ISO)
bis(2-ethylhexyl) phthalate  (EXP)
bisphenol A  (EXP)
cadmium dichloride  (EXP)
calcidiol  (EXP)
calciol  (EXP,ISO)
calcitriol  (EXP,ISO)
calcium atom  (EXP,ISO)
calcium carbonate  (ISO)
calcium(0)  (EXP,ISO)
canagliflozin  (EXP)
captopril  (ISO)
CGP 52608  (ISO)
cinacalcet  (ISO)
copper atom  (EXP)
copper(0)  (EXP)
corticosterone  (EXP)
dexamethasone  (ISO)
epoxiconazole  (ISO)
ethanol  (EXP)
flavonoids  (EXP)
furosemide  (EXP)
gallium nitrate  (EXP)
hydrogen chloride  (ISO)
ketoconazole  (EXP)
lead diacetate  (EXP)
lithium atom  (EXP,ISO)
lithium carbonate  (ISO)
lithium hydride  (EXP,ISO)
Maxacalcitol  (EXP,ISO)
menaquinone  (EXP)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (ISO)
nickel atom  (ISO)
paricalcitol  (ISO)
phenytoin  (ISO)
phosphorus atom  (EXP)
phosphorus(.)  (EXP)
protein kinase inhibitor  (EXP)
raloxifene  (ISO)
sodium arsenite  (ISO)
sodium fluoride  (EXP,ISO)
tamoxifen  (EXP)
Terfenadine  (ISO)
theophylline  (EXP)
Trapidil  (EXP)
trichostatin A  (ISO)
uranium atom  (EXP)
vanadyl sulfate  (ISO)
vinclozolin  (EXP)
vitamin D  (ISO)
vitamin K  (ISO)
warfarin  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
adenylate cyclase-activating G protein-coupled receptor signaling pathway  (IDA,IMP,ISO)
bone mineralization  (ISO)
bone resorption  (TAS)
calcium ion homeostasis  (ISO)
cell-cell signaling  (IBA,IDA)
homeostasis of number of cells within a tissue  (ISO)
intracellular calcium ion homeostasis  (IDA,ISO)
magnesium ion homeostasis  (ISO)
negative regulation of apoptotic process in bone marrow cell  (ISO)
negative regulation of bone mineralization involved in bone maturation  (IMP)
negative regulation of chondrocyte differentiation  (IMP)
negative regulation of gene expression  (ISO)
ossification  (TAS)
phosphate ion homeostasis  (ISO)
positive regulation of bone mineralization  (IDA,ISO)
positive regulation of cell proliferation in bone marrow  (ISO)
positive regulation of gene expression  (IMP)
positive regulation of glucose import  (ISO,ISS)
positive regulation of glycogen biosynthetic process  (ISO,ISS)
positive regulation of inositol phosphate biosynthetic process  (ISO)
positive regulation of ossification  (IDA)
positive regulation of osteoclast proliferation  (ISO)
positive regulation of signal transduction  (ISO)
positive regulation of transcription by RNA polymerase II  (ISO)
regulation of gene expression  (ISO)
response to cadmium ion  (IEP)
response to ethanol  (IEP)
response to fibroblast growth factor  (IEP)
response to lead ion  (IEP)
response to nutrient levels  (IEP)
response to parathyroid hormone  (IEP)
response to vitamin D  (IEP)
response to xenobiotic stimulus  (IEP)
Rho protein signal transduction  (IMP)
signal transduction  (ISO)
transcription by RNA polymerase II  (ISO)

Cellular Component
extracellular space  (IBA,IDA,ISO)

Molecular Function

Molecular Pathway Annotations     Click to see Annotation Detail View

References - curated
# Reference Title Reference Citation
1. Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. Arnold A, etal., J Clin Invest. 1990 Oct;86(4):1084-7.
2. Serum vitamin D levels in children with recurrent otitis media. Cayir A, etal., Eur Arch Otorhinolaryngol. 2013 Mar 30.
3. Impact of frequent nocturnal hemodialysis on myocardial mechanics and cardiomyocyte gene expression. Chan CT, etal., Circ Cardiovasc Imaging. 2012 Jul;5(4):474-80. doi: 10.1161/CIRCIMAGING.111.971606. Epub 2012 May 30.
4. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. Chertow GM, etal., N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.
5. Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats. De Schutter TM, etal., Calcif Tissue Int. 2012 Nov;91(5):307-15. doi: 10.1007/s00223-012-9635-0. Epub 2012 Aug 28.
6. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. De Schutter TM, etal., Kidney Int. 2013 Mar 13. doi: 10.1038/ki.2013.34.
7. New potent calcimimetics: II. Discovery of benzothiazole trisubstituted ureas. Deprez P, etal., Bioorg Med Chem Lett. 2013 Apr 15;23(8):2455-9. doi: 10.1016/j.bmcl.2013.01.077. Epub 2013 Feb 8.
8. Loss-of-function mutations of CYP24A1, the vitamin D 24- hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. Dinour D, etal., J Urol. 2013 Mar 4. pii: S0022-5347(13)03464-2. doi: 10.1016/j.juro.2013.02.3188.
9. Vitamin D Treatment and Mortality in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Duranton F, etal., Am J Nephrol. 2013 Mar 5;37(3):239-248.
10. The effect of PTH(1-34) on fracture healing during different loading conditions. Ellegaard M, etal., J Bone Miner Res. 2013 Apr 13. doi: 10.1002/jbmr.1957.
11. Dietary phosphate binding and loading alter kidney angiotensin-converting enzyme mRNA and protein content in 5/6 nephrectomized rats. Eraranta A, etal., Am J Nephrol. 2012;35(5):401-8. doi: 10.1159/000337942. Epub 2012 Apr 19.
12. Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links. Fisher A, etal., Clin Interv Aging. 2013;8:239-56. doi: 10.2147/CIA.S38856. Epub 2013 Feb 25.
13. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats. Fisher JE, etal., Bone. 2012 Jun;50(6):1332-42. doi: 10.1016/j.bone.2012.03.004. Epub 2012 Mar 14.
14. New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP. Fujita T, etal., J Biol Chem 2002 Jun 21;277(25):22191-200.
15. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
16. Age-related changes in gap junctional intercellular communication in osteoblastic cells. Genetos DC, etal., J Orthop Res. 2012 Dec;30(12):1979-84. doi: 10.1002/jor.22172. Epub 2012 Jun 13.
17. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
18. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients. Gohda T, etal., Am J Kidney Dis. 2002 Jun;39(6):1255-60.
19. Mutual up-regulation of thyroid hormone and parathyroid hormone receptors in rat osteoblastic osteosarcoma 17/2.8 cells. Gu WX, etal., Endocrinology 2001 Jan;142(1):157-64.
20. Significance of HCG to distinguish parathyroid carcinoma from benign disease and in adding prognostic information: a hospital based study from Nepal. Gupta SP, etal., Asian Pac J Cancer Prev. 2013;14(1):325-7.
21. Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransporters. Haller M, etal., PLoS One. 2012;7(7):e39229. doi: 10.1371/journal.pone.0039229. Epub 2012 Jul 30.
22. A prospective randomized pilot study on intermittent post-dialysis dosing of cinacalcet. Haq N, etal., Int Urol Nephrol. 2013 Mar 26.
23. Role of phytoestrogenic oils in alleviating osteoporosis associated with ovariectomy in rats. Hassan HA, etal., Cytotechnology. 2012 Nov 18.
24. Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism. Hofman-Bang J, etal., Int J Nephrol. 2012;2012:123576. doi: 10.1155/2012/123576. Epub 2012 Oct 10.
25. Ferric Citrate Hydrate, a New Phosphate Binder, Prevents the Complications of Secondary Hyperparathyroidism and Vascular Calcification. Iida A, etal., Am J Nephrol. 2013 Mar 23;37(4):346-358.
26. Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity. Iida-Klein A, etal., J Biol Chem. 1997 Mar 14;272(11):6882-9.
27. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats. Jung S, etal., J Hypertens. 2012 Nov;30(11):2182-91. doi: 10.1097/HJH.0b013e328357c049.
28. Parathyroid hormone (1-34) regulates integrin expression in vivo in rat osteoblasts. Kaiser E, etal., J Cell Biochem 2001;83(4):617-30.
29. Parathyroid hormone (PTH) suppresses rat PTH/PTH-related protein receptor gene promoter. Kawane T, etal., Biochem Biophys Res Commun 2001 Sep 21;287(2):313-22.
30. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. Kestenbaum B, etal., J Am Coll Cardiol. 2011 Sep 27;58(14):1433-41. doi: 10.1016/j.jacc.2011.03.069.
31. Excessive ethanol consumption under exposure to lead intensifies disorders in bone metabolism: A study in a rat model. Kupraszewicz E and Brzoska MM, Chem Biol Interact. 2013 Jan 30;203(2):486-501. doi: 10.1016/j.cbi.2013.01.002.
32. The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Lanske B, etal., Endocrinology. 1998 Dec;139(12):5194-204.
33. Parathyroid hormone signaling in bone and kidney. Lee M and Partridge NC, Curr Opin Nephrol Hypertens. 2009 Jul;18(4):298-302. doi: 10.1097/MNH.0b013e32832c2264.
34. Effect of lanthanum carbonate on phosphate control in continuous ambulatory peritoneal dialysis patients in Korea: a randomized prospective study. Lee YK, etal., Clin Nephrol. 2013 Feb;79(2):136-42. doi: 10.5414/CN107362.
35. A comparison of the anabolic effects of rat and bovine parathyroid hormone (1-34) in ovariectomized rats. Li M, etal., J Musculoskelet Neuronal Interact. 2001 Sep;2(1):77-83.
36. Impaired bone formation with a high-protein diet in rats with adriamycin-induced nephrotic syndrome. Lim AY, etal., Kidney Blood Press Res. 2012;35(6):438-44. doi: 10.1159/000336361. Epub 2012 Jun 6.
37. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. London GM, etal., J Am Soc Nephrol. 2008 Sep;19(9):1827-35. doi: 10.1681/ASN.2007050622. Epub 2008 May 14.
38. The parathyroid hormone receptorsome and the potential for therapeutic intervention. Mahon MJ Curr Drug Targets. 2012 Jan;13(1):116-28.
40. Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats. Matsui I, etal., Am J Physiol Renal Physiol. 2013 Mar;304(6):F751-60. doi: 10.1152/ajprenal.00329.2012. Epub 2013 Jan 23.
41. Parathyroid hormone regulates the expression of the receptor protein tyrosine phosphatase, OST-PTP, in rat osteoblast-like cells. Mauro LJ, etal., Endocrinology. 1996 Mar;137(3):925-33. doi: 10.1210/endo.137.3.8603605.
42. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
43. The Bone-Protective Effect of Genistein in the Animal Model of Bilateral Ovariectomy: Roles of Phytoestrogens and PTH/PTHR1 Against Post-Menopausal Osteoporosis. Miao Q, etal., Int J Mol Sci. 2012;13(1):56-70. doi: 10.3390/ijms13010056. Epub 2011 Dec 22.
44. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. Moe SM, etal., J Bone Miner Res. 2011 Nov;26(11):2672-81. doi: 10.1002/jbmr.485.
45. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
46. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
47. Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study. Panuccio V, etal., BMC Nephrol. 2012 Oct 9;13:134. doi: 10.1186/1471-2369-13-134.
48. A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Parkinson DB and Thakker RV, Nat Genet. 1992 May;1(2):149-52.
49. Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. Radeff JM, etal., J Bone Miner Res. 2004 Nov;19(11):1882-91. Epub 2004 Aug 16.
50. GOA pipeline RGD automated data pipeline
51. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
52. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
53. Comprehensive gene review and curation RGD comprehensive gene curation
54. Calcium deficiency reduces circulating levels of FGF23. Rodriguez-Ortiz ME, etal., J Am Soc Nephrol. 2012 Jul;23(7):1190-7. doi: 10.1681/ASN.2011101006. Epub 2012 May 10.
55. Occurrence of cardiovascular calcifications in normal, aging rats. Roosens B, etal., Exp Gerontol. 2012 Aug;47(8):614-9. doi: 10.1016/j.exger.2012.05.012. Epub 2012 May 24.
56. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements. Russell J, etal., J Bone Miner Res 1999 Nov;14(11):1828-37.
57. The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program. Saab G, etal., J Clin Endocrinol Metab. 2012 Dec;97(12):4414-21. doi: 10.1210/jc.2012-2001. Epub 2012 Oct 12.
58. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice. Santana AC, etal., Nephrol Dial Transplant. 2013 Jan 22.
59. Mineral metabolites and CKD progression in African Americans. Scialla JJ, etal., J Am Soc Nephrol. 2013 Jan;24(1):125-35. doi: 10.1681/ASN.2012070713. Epub 2012 Dec 14.
60. Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development. Segawa H, etal., Am J Physiol Renal Physiol. 2009 Sep;297(3):F671-8. doi: 10.1152/ajprenal.00156.2009. Epub 2009 Jul 1.
61. Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. Shimizu N, etal., J Biol Chem. 2001 Dec 28;276(52):49003-12. Epub 2001 Oct 16.
62. Phosphorus as an early marker of morbidity and mortality in type 2 chronic kidney disease diabetic patients. Silva AP, etal., J Diabetes Complications. 2013 Mar 22. pii: S1056-8727(13)00053-6. doi: 10.1016/j.jdiacomp.2013.02.007.
63. Effects of dietary Pi on the renal Na+-dependent Pi transporter NaPi-2 in thyroparathyroidectomized rats. Takahashi F, etal., Biochem J. 1998 Jul 1;333 ( Pt 1):175-81.
64. Fibroblast growth factor 23 enhances renal klotho abundance. Takenaka T, etal., Pflugers Arch. 2013 Mar 7.
65. Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study). van Ballegooijen AJ, etal., Am J Cardiol. 2013 Feb 1;111(3):418-24. doi: 10.1016/j.amjcard.2012.10.021. Epub 2012 Nov 17.
66. Polymorphisms in the vitamin d receptor gene and parathyroid hormone gene in the development and progression of diabetes mellitus and its chronic complications, diabetic nephropathy and non-diabetic renal disease. Vedralova M, etal., Kidney Blood Press Res. 2012;36(1):1-9. doi: 10.1159/000339021. Epub 2012 Jun 18.
67. Osteosarcoma in Sprague-Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1-34)). Watanabe A, etal., J Toxicol Sci. 2012;37(3):617-29.
68. Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle. Wilson MC, etal., J Biol Chem. 2009 Jul 24;284(30):20011-21. doi: 10.1074/jbc.M109.014217. Epub 2009 May 27.
69. Two Novel Vitamin D Receptor Modulators with Similar Structures Exhibit Different Hypercalcemic Effects in 5/6 Nephrectomized Uremic Rats. Wu-Wong JR, etal., Am J Nephrol. 2013 Mar 20;37(4):310-319.
70. Mapping the time-dependent effects of paricalcitol on serum calcium, phosphorus and parathyroid hormone levels in 5/6 nephrectomized uremic rats. Wu-Wong JR, etal., Life Sci. 2013 Feb 7;92(2):161-6. doi: 10.1016/j.lfs.2012.11.018. Epub 2012 Dec 19.
71. Cadmium impact and osteoporosis: mechanism of action. Youness ER, etal., Toxicol Mech Methods. 2012 Sep;22(7):560-7. doi: 10.3109/15376516.2012.702796.
72. Effects of phosphonoformic acid and renagel on renal type IIa sodium-dependent phosphate cotransporter mRNA expression in hyperphosphatemia rats. Zeng M, etal., Ren Fail. 2012;34(3):358-63. doi: 10.3109/0886022X.2011.647341. Epub 2012 Jan 20.
73. Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD. Zhang Q, etal., J Am Soc Nephrol. 2011 Apr;22(4):664-72. Epub 2011 Feb 18.
Additional References at PubMed
PMID:90087   PMID:3628009   PMID:6321505   PMID:7588314   PMID:11606467   PMID:12488435   PMID:12581861   PMID:12631114   PMID:14514685   PMID:14517210   PMID:14672346   PMID:15514034  
PMID:15601867   PMID:15601870   PMID:15910753   PMID:16494524   PMID:17565271   PMID:17696759   PMID:17992255   PMID:18165223   PMID:18583400   PMID:19075196   PMID:19129257   PMID:19423655  
PMID:19628670   PMID:19674967   PMID:19723499   PMID:19968565   PMID:20097749   PMID:20627105   PMID:20971569   PMID:21048959   PMID:21076856   PMID:21209610   PMID:21343254   PMID:23344572  
PMID:24103811   PMID:24259513   PMID:24904057   PMID:24940803   PMID:26669699   PMID:27989797   PMID:29529595   PMID:29633272   PMID:33945189  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr81176,942,901 - 176,946,034 (-)NCBIGRCr8
mRatBN7.21167,508,121 - 167,511,530 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1167,508,598 - 167,511,530 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1175,843,980 - 175,846,912 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01183,030,070 - 183,033,002 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01175,725,437 - 175,728,369 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01178,215,829 - 178,218,761 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1178,215,829 - 178,218,761 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01185,183,456 - 185,186,388 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41171,240,596 - 171,243,528 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11171,360,529 - 171,363,462 (-)NCBI
Celera1165,378,267 - 165,381,199 (-)NCBICelera
Cytogenetic Map1q33NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh381113,492,054 - 13,496,181 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1113,492,054 - 13,496,181 (-)EnsemblGRCh38hg38GRCh38
GRCh371113,513,601 - 13,517,728 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361113,470,177 - 13,474,143 (-)NCBINCBI36Build 36hg18NCBI36
Build 341113,470,177 - 13,474,143NCBI
Celera1113,639,772 - 13,643,738 (-)NCBICelera
Cytogenetic Map11p15.3NCBI
HuRef1113,193,715 - 13,197,681 (-)NCBIHuRef
CHM1_11113,512,571 - 13,516,537 (-)NCBICHM1_1
T2T-CHM13v2.01113,584,795 - 13,588,918 (-)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm397112,984,783 - 112,987,879 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl7112,984,787 - 112,987,777 (-)EnsemblGRCm39 Ensembl
GRCm387113,385,576 - 113,388,672 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl7113,385,580 - 113,388,570 (-)EnsemblGRCm38mm10GRCm38
MGSCv377120,529,090 - 120,532,087 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv367113,176,759 - 113,179,753 (-)NCBIMGSCv36mm8
Celera7113,358,705 - 113,361,703 (-)NCBICelera
Cytogenetic Map7F1NCBI
cM Map759.19NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_00495541428,825,651 - 28,831,117 (-)EnsemblChiLan1.0
ChiLan1.0NW_00495541428,828,389 - 28,831,417 (-)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan1-v2915,932,137 - 15,936,264 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11115,894,484 - 15,898,611 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01113,653,777 - 13,657,901 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11113,347,829 - 13,351,951 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1113,347,838 - 13,351,802 (-)Ensemblpanpan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.12136,417,062 - 36,419,967 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl2136,417,058 - 36,419,967 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha2135,920,892 - 35,923,798 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.02137,300,338 - 37,303,244 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl2137,300,334 - 37,303,244 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.12136,558,731 - 36,561,637 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.02136,734,945 - 36,737,853 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.02137,024,013 - 37,026,919 (-)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_02440494749,049,606 - 49,050,285 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365285,083,596 - 5,084,030 (+)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049365285,081,569 - 5,084,030 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl245,757,398 - 45,760,415 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1245,757,398 - 45,760,433 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2249,290,017 - 49,290,981 (-)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.1151,327,555 - 51,330,810 (+)NCBIChlSab1.1ChlSab1.1chlSab2
Vero_WHO_p1.0NW_023666038148,907,988 - 148,910,728 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_0046247665,489,800 - 5,492,871 (-)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046247665,489,857 - 5,492,777 (-)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Pth
4 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:35
Count of miRNA genes:27
Interacting mature miRNAs:33
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
10059597Bp377Blood pressure QTL 3773.420.025arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)132737458199368955Rat
634314Niddm44Non-insulin dependent diabetes mellitus QTL 44blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)149393289199050459Rat
1578780Cm52Cardiac mass QTL 523.30.0001heart mass (VT:0007028)heart wet weight (CMO:0000069)181591954219808434Rat
724521Uae1Urinary albumin excretion QTL 13.80.0001urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)190508614173018436Rat
1358902Bw47Body weight QTL 471.67body mass (VT:0001259)body weight (CMO:0000012)190508614180359386Rat
1331793Bp200Blood pressure QTL 2003.71601arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)194494440172949803Rat
1331751Bp199Blood pressure QTL 1993.60022arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)194494440181830018Rat
1331749Hrtrt11Heart rate QTL 112.973heart pumping trait (VT:2000009)heart rate (CMO:0000002)194494440198211706Rat
70209Niddm23Non-insulin dependent diabetes mellitus QTL 232.82blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)194494440198324465Rat
731168Bp154Blood pressure QTL 1543.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)194642644214537671Rat
8655649Arrd1Age-related retinal degeneration QTL 14.89retinal layer morphology trait (VT:0003727)percentage of study population developing retinopathy during a period of time (CMO:0002453)1100357752183970443Rat
1354591Cm36Cardiac mass QTL 364.1heart left ventricle mass (VT:0007031)calculated heart weight (CMO:0000073)1102813953201278233Rat
1354615Cm32Cardiac mass QTL 325.2heart left ventricle mass (VT:0007031)heart left ventricle wet weight (CMO:0000071)1102813953201278233Rat
1354606Bp246Blood pressure QTL 2463.6arterial blood pressure trait (VT:2000000)pulse pressure (CMO:0000292)1102813953218753816Rat
1300158Bp173Blood pressure QTL 1733.48arterial blood pressure trait (VT:2000000)blood pressure time series experimental set point of the baroreceptor response (CMO:0002593)1115540693185145286Rat
7794788Mcs32Mammary carcinoma susceptibility QTL 322.61mammary gland integrity trait (VT:0010552)mammary tumor incidence/prevalence measurement (CMO:0000946)1115540693238914717Rat
631199Cm23Cardiac mass QTL 234.60.0004heart left ventricle mass (VT:0007031)heart left ventricle wet weight (CMO:0000071)1115585465172949803Rat
7421630Bp362Blood pressure QTL 3620.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1118608292241799120Rat
631205Bp196Blood pressure QTL 19640.0001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1118944897199050459Rat
631544Bp84Blood pressure QTL 845.6arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1123350408181759564Rat
1358189Cstrr1Cold stress response QTL 10.0001catecholamine amount (VT:0010543)urine norepinephrine level (CMO:0001629)1123350408182418476Rat
1641895Bp298Blood pressure QTL 298arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1123350408182418476Rat
1578770Stresp23Stress response QTL 23kidney sympathetic nerve activity (VT:0004050)stimulated renal sympathetic nerve activity to basal renal sympathetic nerve activity ratio (CMO:0001786)1123350408182418476Rat
631549Bp89Blood pressure QTL 895.7arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1123350581201284552Rat
634348Bp138Blood pressure QTL 138arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1125611501168883176Rat
9685799Bp375Blood pressure QTL 375arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1125611501170611501Rat
631654Bp107Blood pressure QTL 107arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1125611501170611501Rat
9685802Bp376Blood pressure QTL 376arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1126540680171540680Rat
738006Anxrr14Anxiety related response QTL 1440.00035locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)1130636910175636910Rat
738028Anxrr12Anxiety related response QTL 124.90.00001locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)1130636910175636910Rat
6893347Bw98Body weight QTL 980.20.53body mass (VT:0001259)body weight (CMO:0000012)1133680936178680936Rat
6893361Bw104Body weight QTL 1040.590.27body mass (VT:0001259)body weight (CMO:0000012)1133680936178680936Rat
1558645Bw55Body weight QTL 553.20.004body mass (VT:0001259)body weight (CMO:0000012)1133680936178680936Rat
71118Thym1Thymus enlargement QTL 110.170.001thymus mass (VT:0004954)thymus weight to body weight ratio (CMO:0000612)1136829932181829932Rat
724550Thym3Thymus enlargement QTL 37.820.001thymus mass (VT:0004954)thymus weight to body weight ratio (CMO:0000612)1136829932181829932Rat
631519Pia11Pristane induced arthritis QTL 115.3joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1136830018181830018Rat
1598853Memor3Memory QTL 34.5exploratory behavior trait (VT:0010471)total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443)1143506580212458660Rat
61348Bp30Blood pressure QTL 302.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1144017057197814409Rat
70160Bw18Body weight QTL 185.7body mass (VT:0001259)body weight (CMO:0000012)1144267353196383668Rat
737828Hcas3Hepatocarcinoma susceptibility QTL 34.9liver integrity trait (VT:0010547)liver tumorous lesion volume to total liver volume ratio (CMO:0001082)1144267353222987745Rat
2302378Insul11Insulin level QTL 113.25blood insulin amount (VT:0001560)serum insulin level (CMO:0000358)1144267353251128347Rat
634315Niddm45Non-insulin dependent diabetes mellitus QTL 457.16blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)1144267916172949660Rat
61379Bp44Blood pressure QTL 4419.2arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1144267916174133260Rat
7771612Cm80Cardiac mass QTL 808.4heart left ventricle mass (VT:0007031)heart left ventricle weight (CMO:0000776)1149448574221264292Rat
724531Uae5Urinary albumin excretion QTL 54urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)1150700142252085212Rat
1578759Uae30Urinary albumin excretion QTL 303.30.003urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1150700247252085048Rat
1578778Pur4Proteinuria QTL 43.30.003urine total protein amount (VT:0000032)urine total protein excretion rate (CMO:0000756)1150700247252085048Rat
1354602Bw35Body weight QTL 3512.2body mass (VT:0001259)body weight (CMO:0000012)1151162512201278233Rat
1354620Kidm19Kidney mass QTL 194kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1151162512201278233Rat
1354634Kidm12Kidney mass QTL 123.9kidney mass (VT:0002707)right kidney wet weight (CMO:0000082)1151162512201278233Rat
1354636Lmblg1Limb length QTL 16.4tibia length (VT:0004357)tibia length (CMO:0000450)1151162512201278233Rat
1354610Bw34Body weight QTL 344.1body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1354646Kidm18Kidney mass QTL 185.7kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1151162512256448636Rat
1354661Bw33Body weight QTL 335.2body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1358886Bp260Blood pressure QTL 2603.67arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1151162766225824951Rat
61343Bp28Blood pressure QTL 28arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1151646613196646613Rat
1549837Hcar15Hepatocarcinoma resistance QTL 150.05liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1153136852260522016Rat
2303622Vencon6Ventilatory control QTL 60.001respiration trait (VT:0001943)respiration rate (CMO:0000289)1154561505199561505Rat
1582204Livw1Liver weight QTL 13.60.0003liver mass (VT:0003402)liver weight to body weight ratio (CMO:0000633)1155422851172949803Rat
4889428Stresp24Stress response QTL 240.05heart pumping trait (VT:2000009)absolute change in electrocardiographic low frequency R-R spectral component to high frequency R-R spectral component ratio (CMO:0002162)1155866514200866514Rat
631548Bp88Blood pressure QTL 8850.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1156677124176484451Rat
1354618Kidm15Kidney mass QTL 155kidney mass (VT:0002707)left kidney wet weight (CMO:0000083)1156677124201278233Rat
2312420Pur17Proteinuria QTL 177.10.0001urine protein amount (VT:0005160)urine total protein excretion rate (CMO:0000756)1156677124218753816Rat
1354580Scort1Serum corticosterone level QTL 13.4blood corticosterone amount (VT:0005345)blood corticosterone level (CMO:0001172)1156677124256448636Rat
61347Bp197Blood pressure QTL 1974.2arterial blood pressure trait (VT:2000000)blood pressure measurement (CMO:0000003)1158633083203633083Rat
2292222Bp307Blood pressure QTL 3073.060.0014arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164310393213533942Rat
2292220Bp306Blood pressure QTL 3063.470.00087arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164310393243914901Rat
619613Bp77Blood pressure QTL 770.01arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164747424209747424Rat
619613Bp77Blood pressure QTL 770.01arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)1164747424209747424Rat
737974Bp161Blood pressure QTL 1610.002arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1164747558181133855Rat
2312558Glom17Glomerulus QTL 173.90.001kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)1166532971191278129Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21167,512,327 - 167,512,481 (+)MAPPERmRatBN7.2
Rnor_6.01178,219,559 - 178,219,712NCBIRnor6.0
Rnor_5.01185,187,186 - 185,187,339UniSTSRnor5.0
RGSC_v3.41171,244,325 - 171,244,479RGDRGSC3.4
RGSC_v3.41171,244,326 - 171,244,479UniSTSRGSC3.4
RGSC_v3.11171,364,259 - 171,364,413RGD
Celera1165,381,997 - 165,382,150UniSTS
RH 3.4 Map11317.39UniSTS
RH 3.4 Map11317.39RGD
RH 2.0 Map1872.4RGD
Cytogenetic Map1q34UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21167,512,331 - 167,512,469 (+)MAPPERmRatBN7.2
Rnor_6.01178,219,563 - 178,219,700NCBIRnor6.0
Rnor_5.01185,187,190 - 185,187,327UniSTSRnor5.0
RGSC_v3.41171,244,329 - 171,244,467RGDRGSC3.4
RGSC_v3.41171,244,330 - 171,244,467UniSTSRGSC3.4
RGSC_v3.11171,364,263 - 171,364,401RGD
Celera1165,382,001 - 165,382,138UniSTS
Cytogenetic Map1q34UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21167,512,365 - 167,512,576 (+)MAPPERmRatBN7.2
Rnor_6.01178,219,597 - 178,219,807NCBIRnor6.0
Rnor_5.01185,187,224 - 185,187,434UniSTSRnor5.0
RGSC_v3.41171,244,363 - 171,244,574RGDRGSC3.4
RGSC_v3.41171,244,364 - 171,244,574UniSTSRGSC3.4
RGSC_v3.11171,364,297 - 171,364,508RGD
Celera1165,382,035 - 165,382,245UniSTS
Cytogenetic Map1q34UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21167,508,848 - 167,509,264 (+)MAPPERmRatBN7.2
Rnor_6.01178,216,080 - 178,216,495NCBIRnor6.0
Rnor_5.01185,183,707 - 185,184,122UniSTSRnor5.0
RGSC_v3.41171,240,847 - 171,241,262UniSTSRGSC3.4
Celera1165,378,518 - 165,378,933UniSTS
Cytogenetic Map1q34UniSTS


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system endocrine system hemolymphoid system nervous system reproductive system respiratory system
Low 2 7 7
Below cutoff 1 1 3 1 3 2


RefSeq Acc Id: ENSRNOT00000019199   ⟹   ENSRNOP00000019199
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1167,508,598 - 167,511,530 (-)Ensembl
Rnor_6.0 Ensembl1178,215,829 - 178,218,761 (-)Ensembl
RefSeq Acc Id: NM_017044   ⟹   NP_058740
Rat AssemblyChrPosition (strand)Source
GRCr81176,943,102 - 176,946,034 (-)NCBI
mRatBN7.21167,508,598 - 167,511,530 (-)NCBI
Rnor_6.01178,215,829 - 178,218,761 (-)NCBI
Rnor_5.01185,183,456 - 185,186,388 (-)NCBI
RGSC_v3.41171,240,596 - 171,243,528 (-)RGD
Celera1165,378,267 - 165,381,199 (-)RGD
RefSeq Acc Id: XM_039100789   ⟹   XP_038956717
Rat AssemblyChrPosition (strand)Source
GRCr81176,942,901 - 176,944,311 (-)NCBI
mRatBN7.21167,508,121 - 167,509,807 (-)NCBI
RefSeq Acc Id: NP_058740   ⟸   NM_017044
- Peptide Label: precursor
- UniProtKB: Q63473 (UniProtKB/Swiss-Prot),   P04089 (UniProtKB/Swiss-Prot),   A6I885 (UniProtKB/TrEMBL),   Q80WZ2 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000019199   ⟸   ENSRNOT00000019199
RefSeq Acc Id: XP_038956717   ⟸   XM_039100789
- Peptide Label: isoform X1
- UniProtKB: P04089 (UniProtKB/Swiss-Prot),   Q63473 (UniProtKB/Swiss-Prot),   A6I885 (UniProtKB/TrEMBL),   Q80WZ2 (UniProtKB/TrEMBL)

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P04089-F1-model_v2 AlphaFold P04089 1-115 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:6850034
Promoter ID:EP07108
Type:single initiation site
Description:Parathyroid hormone.
SO ACC ID:SO:0000170
Source:EPD (Eukaryotic Promoter Database,
Notes:homology_group=Homology group 171; Mammalian parathyroid hormone, promoter 1.
Tissues & Cell Lines:parathyroid gland
Experiment Methods:Nuclease protection with homologous sequence ladder; Sequencing of a full-length cDNA
Rat AssemblyChrPosition (strand)Source
RGSC_v3.41171,243,530 - 171,243,590EPD

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:3440 AgrOrtholog
BioCyc Gene G2FUF-57765 BioCyc
Ensembl Genes ENSRNOG00000014318 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
  ENSRNOG00055023985 UniProtKB/Swiss-Prot
  ENSRNOG00060016614 UniProtKB/Swiss-Prot
  ENSRNOG00065029760 UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000019199 ENTREZGENE
  ENSRNOT00000019199.3 UniProtKB/Swiss-Prot
  ENSRNOT00055041190 UniProtKB/Swiss-Prot
  ENSRNOT00060028459 UniProtKB/Swiss-Prot
  ENSRNOT00065051415 UniProtKB/Swiss-Prot
InterPro PTH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTH/PTH-rel UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:24694 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR10541 UniProtKB/Swiss-Prot
Pfam Parathyroid UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Pth PhenoGen
PIRSF PTH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
RatGTEx ENSRNOG00000014318 RatGTEx
  ENSRNOG00055023985 RatGTEx
  ENSRNOG00060016614 RatGTEx
  ENSRNOG00065029760 RatGTEx
SMART PTH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  P04089 ENTREZGENE, UniProtKB/Swiss-Prot
UniProt Secondary Q63473 UniProtKB/Swiss-Prot

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2002-06-10 Pth  parathyroid hormone      Symbol and Name status set to approved 70586 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_disease both inadequate and excessive secretion may lead to bone disorders 61525
gene_disease both inadequate and excessive secretion may lead to bone disorders 70297
gene_function induces intracellular calcium transients in osteoblastic cells, induces CREB phosphorylation through cAMP-dependent protein kinase A 61525
gene_function induces intracellular calcium transients in osteoblastic cells, induces CREB phosphorylation through cAMP-dependent protein kinase A 70297
gene_process stimulates anabolic and catabolic processes in bone 61525
gene_process stimulates anabolic and catabolic processes in bone 70297